IL6 and cardiac arrest: Our data therefore suggest that astrocyte IL-6 production may represent a potential therapeutic target45,46 as reducing cerebral IL-6 production is associated with reduced apoptotic signaling following cardiac arrest.44 To this effect, clinical trials assessing the influence of IL-6 receptor blockade with Tocilizumab on outcome following cardiac arrest are ongoing (NCT03863015).